Proactive Investors - Run By Investors For Investors

Shares of Valeritas Holdings jump after data-release underscores performance of flagship V-Go device

The New Jersey company says the data show the V-Go therapy resulted in better glycemic control and was well tolerated by patients
The commercial-stage company focuses on development and commercialization of medical technologies to treat patients with Type 2 diabetes in the US

Shares of Valeritas Holdings Inc (NASDAQ:VLRX) jumped Wednesday after releasing more data underscoring the quality and performance of its flagship V-Go Wearable Insulin Delivery device.

Valeritas’ stock recently traded up 6.6% to $4.02 a share on heavier-than-average volume. In pre-market trading, shares rose as high as 31%. 

The Bridgewater, New Jersey, medical-tech company said the data demonstrate that the V-Go therapy resulted in better glycemic control and improved attainment of quality performance measures, and was well tolerated by patients.

READ: Orgenesis showcases publication of diabetes study in Stem Cell Research and Therapy Journal

The data were pulled from the VERDICT study -- a real-world retrospective analysis of electronic health records from a large specialized diabetes center -- and announced at the International Society for Pharmacoeconomics and Outcomes Research's annual meeting in New Orleans, according to a statement.

“The VERDICT study demonstrates that significantly more patients achieved better control and attained improved quality metrics," said CEO John Timberlake. “We will continue to partner with clinicians to improve patient outcomes and quality of care delivered using V-Go as a standard way to deliver basal-bolus insulin therapy.”

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

View full VLRX profile View Profile

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use